Dutch Unlikely To Meet Nuclear Security Summit Promise on Reactor Conversion

A general view of the 2012 Seoul Nuclear Security Summit in March 2012 in Seoul, South Korea. The Netherlands is unlikely to meet a reactor conversion deadline established there.
National Journal
Douglas P. Guarino
March 14, 2014, 11:15 a.m.

The Neth­er­lands — host of this month’s bi­en­ni­al Nuc­le­ar Se­cur­ity Sum­mit in The Hag­ue — will likely be un­able to meet a com­mit­ment it made at the last such meet­ing of world lead­ers in South Korea, doc­u­ments re­leased Thursday by a watch­dog group show.

At the 2012 sum­mit, the United States, France, Bel­gi­um and the Neth­er­lands agreed to col­lab­or­ate to­wards pro­du­cing med­ic­al iso­topes without use of weapons-grade highly en­riched urani­um by 2015. Un­der the deal, Dutch pro­du­cer Mallinck­rodt was ex­pec­ted to con­vert its re­act­ors to low en­riched urani­um by that time.

However, in a Decem­ber 2013 present­a­tion to U.S. of­fi­cials, the com­pany re­ferred to the 2015 date that the four coun­tries agreed to as an “ag­gress­ive, as­pir­a­tion­al goal.” The Uni­versity of Texas-Aus­tin’s Nuc­le­ar Pro­lif­er­a­tion Pre­ven­tion Pro­ject ob­tained a copy of the present­a­tion, and made it pub­lic, along with oth­er re­lated doc­u­ments.

“Des­pite our best ef­forts for con­ver­sion, we have run in­to some tech­nic­al is­sues which have delayed the pro­ject,” read the brief­ing slides by Mallinck­rodt Stra­tegic Al­li­ances Dir­ect­or Roy Brown. “These delays will likely re­quire HEU ship­ments throughout 2015 and 2016 to as­sure pa­tient needs are met, be­fore full con­ver­sion to LEU is at­tained.”

Com­pany and Dutch gov­ern­ment of­fi­cials sub­sequently con­firmed the delay in Jan. 27 and Feb. 16 let­ters to Alan Ku­per­man, co­ordin­at­or for the Nuc­le­ar Pro­lif­er­a­tion Pre­ven­tion Pro­ject.

Ku­per­man, an as­so­ci­ate pro­fess­or at the Uni­versity of Texas-Aus­tin and a former con­gres­sion­al aide, said Brown re­it­er­ated the delay again on Wed­nes­day at a White House meet­ing. Ku­per­man, who was present at the meet­ing, said com­pany of­fi­cials cited a new 2017 tar­get date for LEU con­ver­sion, but im­plied that there could even be fur­ther delays bey­ond that.

U.S. En­ergy De­part­ment of­fi­cials, who also par­ti­cip­ated in the Wed­nes­day meet­ing and who lead Obama ad­min­is­tra­tion ef­forts to re­duce pro­lif­er­a­tion con­cerns re­lated to med­ic­al iso­topes, could not be reached for com­ment.

Mallinck­rodt spokes­wo­man Lynn Phil­lips on Fri­day said she could not dis­cuss the com­pany’s dis­cus­sions with gov­ern­ment of­fi­cials, but con­firmed it had ex­per­i­enced delays in the con­ver­sion pro­gram. The com­pany con­tin­ues to work “di­li­gently”  to­ward con­ver­sion, but a “self-im­posed” 2015 dead­line that she said the com­pany had set a year pri­or to the 2012 sum­mit had been pushed back to 2017. She noted this new tar­get date was in ad­vance of 2020, when the United States plans to halt HEU ex­ports.

Ku­per­man, along with two oth­er U.S.-based act­iv­ists, wrote to Dutch gov­ern­ment of­fi­cials on Jan. 22 and urged them to in­ter­vene. Spe­cific­ally, they asked the Dutch gov­ern­ment, which will host the 2014 sum­mit in less than two weeks, to per­suade Mallinck­rodt to ac­cept U.S. fin­an­cial and tech­nic­al as­sist­ance in or­der to speed the con­ver­sion pro­cess. The U.S. En­ergy De­part­ment has provided fin­an­cial as­sist­ance for con­ver­sion ef­forts in Bel­gi­um and South Africa, but Ku­per­man claims the Mallinck­rodt ini­tially re­fused such aid for its op­er­a­tions in the Neth­er­lands, cit­ing con­ver­sa­tions with U.S. of­fi­cials.

“It would be a grave em­bar­rass­ment for your coun­try at the forth­com­ing sum­mit if the Neth­er­lands were not per­ceived as do­ing everything pos­sible to meet its com­mit­ment from the pre­ced­ing sum­mit,” said the let­ter, signed by Ku­per­man, Prin­ceton Uni­versity Seni­or Re­search Phys­i­cist Frank von Hip­pel and Uni­on of Con­cerned Sci­ent­ists Seni­or Sci­ent­ist Ed­win Ly­man.

Piet de Klerk, the Dutch for­eign min­istry of­fi­cial or­gan­iz­ing the sum­mit, re­spon­ded to the let­ter on Feb. 26. He said Mallinck­rodt had “re­star­ted dis­cus­sions with the U.S. De­part­ment of En­ergy about po­ten­tial fund­ing of a por­tion of the con­ver­sion costs,” but that fin­an­cial as­sist­ance was “not the prime key to suc­cess.”

Ac­cord­ing to de Klerk, over­com­ing tech­nic­al chal­lenges was the most im­port­ant factor in the delay.

“This is a time-con­sum­ing pro­cess of test­ing and re-test­ing, in which every step of the pro­cess, in the in­terest of safety and product qual­ity, has to be ap­proved by the reg­u­lat­ory au­thor­it­ies,” de Klerk wrote. “The Neth­er­lands gov­ern­ment re­mains fully com­mit­ted “¦ and is fully con­fid­ent that the in­dus­tries in­volved will reach the goals set in 2012 as ex­ped­i­tiously as pos­sible.”

Ku­per­man ar­gues, however, that Mallinck­rodt of­fi­cials ad­mit­ted that a lack of ad­equate re­sources was in­deed a factor in the delay. In a Jan. 17 let­ter to Ku­per­man, Brown wrote that Mallinck­rodt ex­per­i­enced un­ex­pec­ted re­act­or shut­downs and main­ten­ance is­sues since the 2012 sum­mit that re­quired the com­pany to “dir­ect sub­stan­tial re­sources to those ef­forts [which] slowed con­ver­sion.”

Phil­lips re­it­er­ated on Fri­day that the re­act­or shut­downs were re­spons­ible for the delays.

Bel­gi­um, Europe’s oth­er ma­jor pro­du­cer of med­ic­al iso­topes, is still ex­pec­ted to meet the 2015 con­ver­sion dead­line, Ku­per­man said. He noted that com­pan­ies in Aus­tralia, South Africa and Ar­gen­tina are already pro­du­cing med­ic­al iso­topes without highly en­riched urani­um.

Ku­per­man chas­tised the Dutch gov­ern­ment for what he said was a fail­ure to act more quickly to en­sure that Mallinck­rodt would en­able the coun­try to com­ply with the sum­mit pact.

“It is a huge em­bar­rass­ment and sets a ter­rible ex­ample when the sum­mit host vi­ol­ates its own pledge,” Ku­per­man said in a writ­ten state­ment Thursday. “‘Do as we say, not as we do’ is not an ef­fect­ive for­eign policy.”

Of­fi­cials at the Dutch em­bassy in Wash­ing­ton were un­able to com­ment by press time.

Un­der the 2012 agree­ment, the United States, which does not cur­rently pro­duce its own med­ic­al iso­topes, agreed to col­lab­or­ate with the European na­tions on their con­ver­sion ef­forts and to con­tin­ue to sup­ply them with highly en­riched urani­um un­til those con­ver­sion ef­forts are com­plete.

What We're Following See More »
DOWN FROM POST-CONVENTION NUMBERS
Monmouth Has Clinton Up Seven
8 minutes ago
THE LATEST

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Source:
DEBATE PREP
Clinton Advisers Talking to Psychologists, Trump Ghostwriter
25 minutes ago
THE LATEST

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

INFLUENCED BY NUKES, POLLUTION
Scientists Declare Dawn of Anthropocene Epoch
2 hours ago
WHY WE CARE

"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."

Source:
EPI-PEN PRICES
House Committee Investigating Mylan
2 hours ago
THE LATEST

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.

Source:
×